1 active not recruiting. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Active not recruiting 1 |
Follow NEC OncoImmunity AS: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| NECVAX-NEO1 in Addition to Checkpoint Inhibitor in Patients With Solid Tumors NECVAX-NEO1 - Solid Tumors, Adult | Phase 1 | Active not recruiting | NEC OncoImmunity AS | 6 | 2022-05-05 | 2025-06-26 |
Lithuania (1)